Federal Register / Vol. 88, No. 196 / Thursday, October 12, 2023 / Notices 70661 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than October 27, 2023. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, IL 60690–1414. Comments can 

also be sent electronically to 

Comments.applications@chi.frb.org: 

1. George B. Bley II, Palm Harbor, 

Florida, individually, and acting in 

concert with the Bley Family Control 

Group; to retain voting shares of 

Petefish, Skiles Bancshares, Inc., and 

thereby indirectly retain voting shares of 

Petefish, Skiles & Company, both of 

Virginia, Illinois. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2023–22582 Filed 10–11–23; 8:45 am] 

BILLING CODE P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than November 13, 2023. 

A. Federal Reserve Bank of Kansas 

City (Jeffrey Imgarten, Assistant Vice 

President) 1 Memorial Drive, Kansas 

City, Missouri 64198–0001. Comments 

can also be sent electronically to 

KCApplicationComments@kc.frb.org: 

1. State Holding, Inc., Richmond, 

Missouri; to become a bank holding 

company by acquiring The State Bank, 

Richmond, Missouri. 

Board of Governors of the Federal Reserve 

System. 

Ann Misback, 

Secretary of the Board. 

[FR Doc. 2023–22590 Filed 10–11–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on Documentation Burden 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for supplemental 

evidence and data submission. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

Documentation Burden, which is 

currently being conducted by the 

AHRQ’s Evidence-based Practice 

Centers (EPC) Program. Access to 

published and unpublished pertinent 

scientific information will improve the 

quality of this review. 

DATES: Submission Deadline on or 

before November 13, 2023. 

ADDRESSES: 

Email submissions: epc@

ahrq.hhs.gov. 

Print submissions: Mailing Address: 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers Lane, 

Mail Stop 06E53A, Rockville, MD 

20857. 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers Lane, 

Mail Stop 06E77D, Rockville, MD 

20857. 

FOR FURTHER INFORMATION CONTACT: 

Kelly Carper, Telephone: 301–427–1656 

or Email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Centers (EPC) 

Program to complete a review of the 

evidence for Documentation Burden. 

AHRQ is conducting this review 

pursuant to Section 902 of the Public 

Health Service Act, 42 U.S.C. 299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Documentation Burden. 

The entire research protocol is available 

online at: https://effectivehealthcare.

ahrq.gov/products/documentationburden/protocol. 

This is to notify the public that the 

EPC Program would find the following 

information on Documentation Burden 

helpful: 

D A list of completed studies that 

your organization has sponsored for this 

topic. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

D For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements, if relevant: study number, 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, primary and secondary 

outcomes, baseline characteristics, 

number of patients screened/eligible/ 

enrolled/lost to follow-up/withdrawn/ 

analyzed, effectiveness/efficacy, and 

safety results. 

D A list of ongoing studies that your 

organization has sponsored for this 

topic. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including, if relevant, a study 

number, the study period, design, 

methodology, indication and diagnosis, 

proper use instructions, inclusion and 

exclusion criteria, and primary and 

secondary outcomes. 

D Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

organization for this topic and an index 


ddrumheller on DSK120RN23PROD with NOTICES1
70662 Federal Register / Vol. 88, No. 196 / Thursday, October 12, 2023 / Notices 

outlining the relevant information in 

each submitted file. 

Your contribution is very beneficial to 

the Program. Materials submitted must 

be publicly available or able to be made 

public. Materials that are considered 

confidential; marketing materials; study 

types not included in the review; or 

information on topics not included in 

the review cannot be used by the EPC 

Program. This is a voluntary request for 

information, and all costs for complying 

with this request must be borne by the 

submitter. 

The draft of this review will be posted 

on AHRQ’s EPC Program website and 

available for public comment for a 

period of 4 weeks. If you would like to 

be notified when the draft is posted, 

please sign up for the email list at: 

https://www.effectivehealthcare.

ahrq.gov/email-updates. 

The review will answer the following 

questions. This information is provided 

as background. AHRQ is not requesting 

that the public provide answers to these 

questions. 

Guiding Questions 

Description/Overview of Measurements 

of Documentation Burden 

(1) What metrics of documentation 

burden that have been developed or 

used (including metrics broadly— 

quantitative and qualitative)? 

(a) For which settings, populations, 

and intended uses were the metrics 

developed? 

(b) How have these metrics been 

applied? 

(c) Is there published information 

available on validity of the metrics? 

(d) What are the key strengths and 

weaknesses of different metrics that 

have been used? 

(2) What are the different perspectives 

on the appropriateness of different 

metrics of documentation burden that 

have been applied/proposed (e.g., 

scalability, resource intensiveness to 

collect, equitable across populations)? 

(3) What are the perceptions of 

documentation burden from the 

perspective of people in different 

clinical roles (e.g., doctor, nurse, etc.) 

and patients/caregivers? 

Factors Influencing Documentation 

Burden 

(4) What is the role of patients in 

documentation burden? 

(5) What is the role of setting (i.e., 

rural vs. urban, hospital, outpatient, 

academic institution, etc.) in 

documentation burden? 

PICOTS (POPULATIONS, INTERVENTIONS, COMPARATORS, OUTCOMES, TIMING, AND SETTINGS) 

PICOTS elements Inclusion criteria Exclusion criteria 

Population ....................................... Healthcare professionals, including but not limited to: ..........................

• Physicians. 

• Nurses. 

• Other professionals. 

• Any healthcare professional 

without direct patient contact. 

Interventions (Exposure) ................. • EHR. ...................................................................................................

• Electronic prescribing. 

• Electronic patient portals. 

• Computerized physician order entry. 

• None. 

Comparators .................................... • None ................................................................................................... • None. 

Outcomes ........................................ Metrics of documentation burden, including but not limited to: ............

• WOW. 

• Time on Inbox. 

• Time on Encounter Note Documentation. 

• Excessive workload. 

• None. 

• Time on EHR. 

• Administrative tasks. 

• Fragmentation of workflow. 

• Physician-patient interaction. 

Timing .............................................. • All ....................................................................................................... • None. 

Settings ........................................... • Any clinical settings ........................................................................... • None. 

Study design ................................... • RCTs. .................................................................................................

• Comparative observational studies. 

• Surveys. 

• Qualitative studies. 

• Mixed-method studies. 

• Systematic review or meta-analysis. 

• In vitro studies. 

• Erratum. 

• Editorials. 

• Letters. 

• Case studies/case reports. 

• Narrative reviews. 

Publications ..................................... • Studies published in English as peer reviewed full-text articles .......

• Published after the year 2000 ...........................................................

• Foreign language studies. 

• Conference abstracts. 

Abbreviations: EHR = electronic health record; RCT = randomized clinical trials; WOW = Work Outside of Work. 

Dated: October 5, 2023. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2023–22503 Filed 10–11–23; 8:45 am] 

BILLING CODE 4160–90–P 


ddrumheller on DSK120RN23PROD with NOTICES1